合計 50 件の最近のインサイダー取引記録が記録されています Virpax Pharmaceuticals, Inc. (VRPX), 内訳は 38 件の買い および 3 件の売り. インサイダー買い総額は $1.98M インサイダー売り総額は $333.22K.
最近活動のある主要インサイダーには Panis Jaydriane, Randhawa Esha, Chaudhry Usama. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — VRPX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-12-17 |
Panis Jaydriane |
Director |
不明 |
- |
- |
- |
- |
| 2024-11-19 |
Randhawa Esha |
Director |
不明 |
- |
- |
- |
- |
| 2024-11-18 |
Chaudhry Usama |
Officer |
不明 |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
不明 |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
RSU 付与（制限付株式） |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
不明 |
- |
- |
- |
- |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
RSU 付与（制限付株式） |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Field Katharyn |
Director |
不明 |
- |
- |
- |
- |
| 2024-07-05 |
Field Katharyn |
Director |
RSU 付与（制限付株式） |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Su Judy |
Director |
不明 |
- |
- |
- |
- |
| 2024-01-29 |
Bruce Gerald W |
Chief Executive Officer |
RSU 付与（制限付株式） |
125,000 |
$0.32 |
$39.73K |
125,000 |
| 2024-01-29 |
Shah Vinay |
Chief Financial Officer |
RSU 付与（制限付株式） |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-29 |
Singh Vanila |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Jambulingam Thani |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Floyd Eric |
Director |
RSU 付与（制限付株式） |
45,000 |
$0.32 |
$14.3K |
45,000 |
| 2024-01-29 |
Sendrow Jerrold |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Dubin Michael F |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Ruskin Barbara |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Mathias Sheila |
Chief Scientific Officer |
RSU 付与（制限付株式） |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-25 |
Mathias Sheila |
Chief Scientific Officer |
処分 |
112,000 |
$0.79 |
$88.48K |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-06-20 |
Shah Vinay |
Officer |
不明 |
- |
- |
- |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-04-24 |
Bruce Gerald W |
Director |
RSU 付与（制限付株式） |
100,000 |
$0.73 |
$73K |
100,000 |
| 2023-03-24 |
Ruskin Barbara |
Director |
不明 |
- |
- |
- |
- |
| 2023-03-24 |
Ruskin Barbara |
Director |
RSU 付与（制限付株式） |
25,000 |
$0.84 |
$20.91K |
25,000 |
| 2023-01-31 |
Mathias Sheila |
Chief Scientific Officer |
処分 |
60,676 |
$2.13 |
$129.24K |
- |
| 2023-01-25 |
Chipman Christopher Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
112,000 |
- |
- |
112,000 |
| 2023-01-25 |
Gudin Jeffrey |
Chief Medical Officer |
RSU 付与（制限付株式） |
50,000 |
- |
- |
50,000 |
| 2023-01-25 |
Mack Anthony P. |
Chief Executive Officer |
RSU 付与（制限付株式） |
125,000 |
- |
- |
125,000 |
| 2023-01-25 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
125,000 |
$0.87 |
$108.38K |
125,000 |
| 2023-01-01 |
Singh Vanila |
Director |
RSU 付与（制限付株式） |
15,000 |
- |
- |
15,000 |
| 2023-01-01 |
Jambulingam Thani |
Director |
RSU 付与（制限付株式） |
40,000 |
- |
- |
40,000 |
| 2023-01-01 |
Floyd Eric |
Director |
RSU 付与（制限付株式） |
45,000 |
- |
- |
45,000 |
| 2023-01-01 |
Sendrow Jerrold |
Director |
RSU 付与（制限付株式） |
35,000 |
- |
- |
35,000 |
| 2023-01-01 |
Dubin Michael F |
Director |
RSU 付与（制限付株式） |
20,000 |
- |
- |
20,000 |
| 2022-05-24 |
Sendrow Jerrold |
Director |
情報に基づく買い |
4,500 |
$1.29 |
$5.81K |
9,006 |
| 2022-05-18 |
Floyd Eric |
Director |
情報に基づく買い |
4,479 |
$1.36 |
$6.11K |
8,018 |
| 2022-05-18 |
Mack Anthony P. |
Chief Executive Officer |
情報に基づく買い |
75,750 |
$1.34 |
$101.51K |
252,562 |
| 2022-04-25 |
Bruce Gerald W |
Director |
RSU 付与（制限付株式） |
60,000 |
- |
- |
60,000 |
| 2022-04-07 |
Mathias Sheila |
Chief Scientific Officer |
処分 |
25,000 |
$4.62 |
$115.5K |
- |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
RSU 付与（制限付株式） |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
150,000 |
$2.34 |
$351K |
150,000 |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
RSU 付与（制限付株式） |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-01 |
Jacob Gary S |
Director |
RSU 付与（制限付株式） |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Singh Vanila |
Director |
RSU 付与（制限付株式） |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Jambulingam Thani |
Director |
RSU 付与（制限付株式） |
14,113 |
$3.43 |
$48.41K |
14,113 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
